Thomas L. Tran - 06 Jan 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: Director
Issuer ticker: CLOV
Reported as of: 06 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jan 2026, 16:04:21 UTC
Prior SEC filing: 08 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/Peter J. Rivas as attorney-in-fact for Thomas L. Tran

Key filing fact

Thomas L. Tran filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 08 Jan 2026.

Key facts

This page summarizes Thomas L. Tran's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jan 2026, 16:04.

Change

Previous filing in this sequence was filed on 08 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001403759 Primary reporting owner

Tran Thomas L

Relationship: Director
Address: C/O CLOVER HEALTH INVESMENTS, CORP, NOT APPLICABLE, WILMINGTON
Signature: /s/Peter J. Rivas as attorney-in-fact for Thomas L. Tran
Signature date: 08 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +79,365
Change %: +79%
Price: $0.000000
Shares after: 180,029
Date: 06 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.